Harvard Bioscience, Inc. (HBIO) Q3 EPS Drops to 5c; Revs Flat
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Join SI Premium – FREE
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q3 EPS of $0.05, versus $0.08 reported last year. Revenue for the quarter came in at $26.38 million, versus $26.45 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue
- Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
